Article
Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution
25 Jun 2022
Abstract excerpt
Heterogeneity is a hallmark of cancer. The advent of single-cell technologies has helped uncover heterogeneity in a high-throughput manner in different cancers across varied contexts. Here we apply single-cell sequencing technologies to reveal inherent heterogeneity in assumptively monoclonal pancreatic cancer (PDAC) cell lines and patient-derived organoids (PDOs). Our findings reveal a high degree of both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
